-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYGLASS PHARMA - NO PRODUCT-RELATED ADVERSE EVENTS REPORTED AT 4-YEAR TIMEPOINT

Reuters·10/19/2026 12:03:02